142 related articles for article (PubMed ID: 21359495)
1. TGF-β1 promotes motility and invasiveness of glioma cells through activation of ADAM17.
Lu Y; Jiang F; Zheng X; Katakowski M; Buller B; To SS; Chopp M
Oncol Rep; 2011 May; 25(5):1329-35. PubMed ID: 21359495
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ADAM17 reduces hypoxia-induced brain tumor cell invasiveness.
Zheng X; Jiang F; Katakowski M; Kalkanis SN; Hong X; Zhang X; Zhang ZG; Yang H; Chopp M
Cancer Sci; 2007 May; 98(5):674-84. PubMed ID: 17355261
[TBL] [Abstract][Full Text] [Related]
3. LRG1 modulates invasion and migration of glioma cell lines through TGF-β signaling pathway.
Zhong D; He G; Zhao S; Li J; Lang Y; Ye W; Li Y; Jiang C; Li X
Acta Histochem; 2015 Jul; 117(6):551-8. PubMed ID: 26049667
[TBL] [Abstract][Full Text] [Related]
4. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
[TBL] [Abstract][Full Text] [Related]
5. ADAM17 promotes glioma cell malignant phenotype.
Zheng X; Jiang F; Katakowski M; Lu Y; Chopp M
Mol Carcinog; 2012 Feb; 51(2):150-64. PubMed ID: 21480393
[TBL] [Abstract][Full Text] [Related]
6. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-β1 signaling pathway.
Kim S; Lee J; Jeon M; Lee JE; Nam SJ
Oncotarget; 2016 Jan; 7(2):1544-58. PubMed ID: 26637807
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor Sp1 induces ADAM17 and contributes to tumor cell invasiveness under hypoxia.
Szalad A; Katakowski M; Zheng X; Jiang F; Chopp M
J Exp Clin Cancer Res; 2009 Sep; 28(1):129. PubMed ID: 19772640
[TBL] [Abstract][Full Text] [Related]
8. Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.
Wu Z; Wang G; Xu S; Li Y; Tian Y; Niu H; Yuan F; Zhou F; Hao Z; Zheng Y; Li Q; Wang J
Tumour Biol; 2014 Mar; 35(3):2205-10. PubMed ID: 24185966
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 inhibits human trophoblast cell invasion by upregulating cyclooxygenase-2.
Yi Y; Cheng JC; Klausen C; Leung PCK
Placenta; 2018 Aug; 68():44-51. PubMed ID: 30055669
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.
Ye XZ; Xu SL; Xin YH; Yu SC; Ping YF; Chen L; Xiao HL; Wang B; Yi L; Wang QL; Jiang XF; Yang L; Zhang P; Qian C; Cui YH; Zhang X; Bian XW
J Immunol; 2012 Jul; 189(1):444-53. PubMed ID: 22664874
[TBL] [Abstract][Full Text] [Related]
11. Structure Identification of ViceninII Extracted from
Luo Y; Ren Z; Du B; Xing S; Huang S; Li Y; Lei Z; Li D; Chen H; Huang Y; Wei G
Molecules; 2019 Jan; 24(1):. PubMed ID: 30609689
[TBL] [Abstract][Full Text] [Related]
12. CCR7 Mediates TGF-β1-Induced Human Malignant Glioma Invasion, Migration, and Epithelial-Mesenchymal Transition by Activating MMP2/9 Through the Nuclear Factor KappaB Signaling Pathway.
Zheng Y; Miu Y; Yang X; Yang X; Zhu M
DNA Cell Biol; 2017 Oct; 36(10):853-861. PubMed ID: 28817313
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1 induced fascin1 expression facilitates the migration and invasion of kidney carcinoma cells through ERK and JNK signaling pathways.
Yang J; Zhang N; Gao R; Zhu Y; Zhang Z; Xu X; Wang J; Li Z; Liu X; Li Z; Li J; Bi J; Kong C
Biochem Biophys Res Commun; 2018 Jul; 501(4):913-919. PubMed ID: 29772238
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta1 regulates the fate of cultured spinal cord-derived neural progenitor cells.
Park SM; Jung JS; Jang MS; Kang KS; Kang SK
Cell Prolif; 2008 Apr; 41(2):248-64. PubMed ID: 18336470
[TBL] [Abstract][Full Text] [Related]
15. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
Kim S; Lee J; You D; Jeong Y; Jeon M; Yu J; Kim SW; Nam SJ; Lee JE
Cell Physiol Biochem; 2018; 45(2):795-807. PubMed ID: 29414799
[TBL] [Abstract][Full Text] [Related]
16. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.
Hjelmeland MD; Hjelmeland AB; Sathornsumetee S; Reese ED; Herbstreith MH; Laping NJ; Friedman HS; Bigner DD; Wang XF; Rich JN
Mol Cancer Ther; 2004 Jun; 3(6):737-45. PubMed ID: 15210860
[TBL] [Abstract][Full Text] [Related]
17. MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells.
Lu Y; Chopp M; Zheng X; Katakowski M; Buller B; Jiang F
Oncol Rep; 2013 Jan; 29(1):67-72. PubMed ID: 23076445
[TBL] [Abstract][Full Text] [Related]
18. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1.
Moreno-Càceres J; Mainez J; Mayoral R; Martín-Sanz P; Egea G; Fabregat I
FEBS J; 2016 Apr; 283(7):1300-10. PubMed ID: 26815118
[TBL] [Abstract][Full Text] [Related]
19. ADAM17 promotes U87 glioblastoma stem cell migration and invasion.
Chen X; Chen L; Chen J; Hu W; Gao H; Xie B; Wang X; Yin Z; Li S; Wang X
Brain Res; 2013 Nov; 1538():151-8. PubMed ID: 23470260
[TBL] [Abstract][Full Text] [Related]
20. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
